NextCure, Inc. (NXTC) insider trading
NextCure, Inc. insiders have made 1 open-market purchase worth $54k since Oct 27, 2026, by 1 insider. The latest: Daniel Schneeberger (10% owner) bought $54k, filed Oct 27, 2026, scored 12 out of 100.
Follow NXTC, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 27 Form 4 (opens sec.gov) |
Daniel Schneeberger10% owner10% owner | +2% stake | 12 | $54k 10,851 at $4.95 |
waiting | waiting |
Investors with more than 5% of NXTC (13D and 13G)
| Filed | Investor | Kind | Stake |
|---|---|---|---|
| Oct 20 13G | JP Sailing Capital Ltd | Passive | 9.9% |
A 13D is filed by an investor who may push for change; a 13G by a passive one.
Insiders who bought NXTC
- Daniel Schneeberger 10% owner
Questions
Are insiders buying NXTC stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $54k.
Who bought NXTC stock most recently?
Daniel Schneeberger, 10% owner, bought 10,851 shares for $54k (Form 4 (opens sec.gov), filed Oct 27, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 27, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer